Washington Trust’s Amgen AMGN Stock Holding History

Washington Trust’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.96M	Buy	11,245 +45	+0.4%	+$16K	0.13%	104
2025 Q4	$3.67M	Sell	11,200 -599	-5%	-$190K	0.12%	108
2025 Q3	$3.33M	Sell	11,799 -182	-2%	-$52.8K	0.11%	112
2025 Q2	$3.35M	Sell	11,981 -2,062	-15%	-$584K	0.12%	110
2025 Q1	$4.38M	Sell	14,043 -3,139	-18%	-$927K	0.17%	103
2024 Q4	$4.48M	Sell	17,182 -29,046	-63%	-$8.62M	0.16%	101
2024 Q3	$14.9M	Sell	46,228 -731	-2%	-$239K	0.52%	66
2024 Q2	$14.7M	Sell	46,959 -1,406	-3%	-$413K	0.54%	59
2024 Q1	$13.8M	Buy	48,365 +91	+0.2%	+$26.6K	0.51%	70
2023 Q4	$13.9M	Sell	48,274 -195	-0.4%	-$53.1K	0.55%	69
2023 Q3	$13M	Sell	48,469 -355	-0.7%	-$88.6K	0.57%	65
2023 Q2	$10.8M	Buy	48,824 +240	+0.5%	+$55.7K	0.46%	77
2023 Q1	$11.7M	Sell	48,584 -488	-1%	-$120K	0.53%	71
2022 Q4	$12.9M	Sell	49,072 -2,040	-4%	-$547K	0.6%	60
2022 Q3	$11.5M	Sell	51,112 -544	-1%	-$132K	0.58%	63
2022 Q2	$12.6M	Sell	51,656 -829	-2%	-$203K	0.59%	65
2022 Q1	$12.7M	Buy	52,485 +2,917	+6%	+$670K	0.5%	75
2021 Q4	$11.2M	Sell	49,568 -282	-0.6%	-$59.5K	0.42%	76
2021 Q3	$10.6M	Buy	49,850 +24	+0%	+$5.52K	0.3%	98
2021 Q2	$12.1M	Buy	49,826 +355	+0.7%	+$87.3K	0.34%	90
2021 Q1	$12.3M	Buy	49,471 +1,095	+2%	+$261K	0.38%	89
2020 Q4	$11.1M	Buy	48,376 +287	+0.6%	+$66.2K	0.36%	89
2020 Q3	$12.2M	Sell	48,089 -274	-0.6%	-$67.9K	0.45%	76
2020 Q2	$11.2M	Buy	48,363 +1,358	+3%	+$310K	0.47%	72
2020 Q1	$9.53M	Sell	47,005 -855	-2%	-$187K	0.45%	75
2019 Q4	$11.5M	Buy	47,860 +435	+0.9%	+$95.9K	0.45%	75
2019 Q3	$10.1M	Buy	47,425 +111	+0.2%	+$21.3K	0.54%	67
2019 Q2	$8.72M	Buy	47,314 +455	+1%	+$81.5K	0.48%	73
2019 Q1	$8.07M	Sell	46,859 -3,409	-7%	-$651K	0.45%	75
2018 Q4	$9.79M	Sell	50,268 -18	-0%	-$3.51K	0.62%	57
2018 Q3	$10.4M	Sell	50,286 -2,390	-5%	-$471K	0.56%	62
2018 Q2	$9.72M	Buy	52,676 +175	+0.3%	+$31K	0.52%	64
2018 Q1	$8.95M	Sell	52,501 -563	-1%	-$103K	0.52%	69
2017 Q4	$9.23M	Buy	53,064 +768	+1%	+$136K	0.52%	67
2017 Q3	$9.75M	Sell	52,296 -286	-0.5%	-$50.7K	0.58%	61
2017 Q2	$9.06M	Buy	52,582 +909	+2%	+$148K	0.55%	63
2017 Q1	$8.48M	Buy	51,673 +549	+1%	+$91.2K	0.54%	65
2016 Q4	$7.47M	Sell	51,124 -1,008	-2%	-$152K	0.48%	70
2016 Q3	$8.7M	Buy	52,132 +139	+0.3%	+$23.5K	0.57%	63
2016 Q2	$7.91M	Buy	51,993 +1,010	+2%	+$157K	0.53%	65
2016 Q1	$7.64M	Buy	50,983 +1,628	+3%	+$242K	0.51%	66
2015 Q4	$8.01M	Sell	49,355 -1,981	-4%	-$311K	0.55%	61
2015 Q3	$7.1M	Buy	51,336 +1,108	+2%	+$175K	0.51%	65
2015 Q2	$7.71M	Buy	50,228 +2,473	+5%	+$396K	0.51%	63
2015 Q1	$7.63M	Buy	47,755 +7,404	+18%	+$1.17M	0.51%	66
2014 Q4	$6.43M	Buy	40,351 +28,268	+234%	+$4.4M	0.44%	81
2014 Q3	$1.7M	Sell	12,083 -47	-0.4%	-$6.14K	0.12%	105
2014 Q2	$1.44M	Sell	12,130 -761	-6%	-$88.1K	0.11%	104
2014 Q1	$1.59M	Sell	12,891 -283	-2%	-$34.3K	0.12%	103
2013 Q4	$1.5M	Sell	13,174 -715	-5%	-$81.3K	0.11%	103
2013 Q3	$1.55M	Buy	13,889 +32	+0.2%	+$3.47K	0.12%	102
2013 Q2	$1.37M	Buy	+13,857	New	+$1.44M	0.12%	104

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Washington Trust's AMGN Position: Q1 2026 in Review

Washington Trust increased its Amgen (AMGN) stake by 0.4% in Q1 2026, buying an estimated $16K and bringing the position to 11,245 shares worth $3.96M. The position accounts for 0.13% of the portfolio, ranked #104.

Washington Trust first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $14.9M in Q3 2024. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Washington Trust held 11,245 shares of Amgen worth $3.96M as of Q1 2026.
Washington Trust bought 45 Amgen shares in Q1 2026, an estimated $16K.
Amgen made up 0.13% of Washington Trust's portfolio in Q1 2026, its #104 holding.
Washington Trust first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
Washington Trust's Amgen position peaked at $14.9M in Q3 2024.
3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Washington Trust's 13F filing for Q1 2026, filed 6 Apr 2026.